Park Ha Biological Technology Announces 1-for-50 Reverse Stock Split to Maintain Nasdaq Listing
BYAH sits 71% above its 52-week low of $0.055.
Summary
Park Ha Biological Technology announced a 1-for-50 reverse stock split, effective February 20, 2026, a common move for micro-cap companies to meet exchange listing requirements.
Key Events · Financing and Capital Events · BYAH
-
Reverse Stock Split Announced
The company will implement a 1-for-50 reverse stock split, effective February 20, 2026, with trading on a split-adjusted basis beginning the same day.
-
Corporate Approvals
The reverse split was approved by shareholders on December 26, 2025, and subsequently by the Board of Directors on January 29, 2026.
-
Charter Amendment Filed
An Amended and Restated Memorandum of Association was filed on February 4, 2026, to reduce the authorized share capital and adjust the par value of shares in connection with the split.
Analysis · BYAH · Industrial Applications And Services
Park Ha Biological Technology Co., Ltd. announced a 1-for-50 reverse stock split, effective February 20, 2026. This action is typically undertaken by micro-cap companies with very low share prices to meet minimum bid price requirements for continued listing on exchanges like Nasdaq. While a reverse split does not change the company's fundamental value, it often signals financial distress and can be viewed negatively by investors, potentially leading to further price erosion post-split. The move follows shareholder approval in December 2025 and board approval in January 2026, and an amended corporate charter was filed to facilitate the change.
At the time of this filing, BYAH was trading at $0.09 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.05 to $41.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.